Are vivid dreams or nightmares a known Ozempic side effect?

The FDA label for Ozempic does not list dreams or nightmares among its adverse reactions. Nightmares do appear elsewhere for a specific reason: NIDDK lists them as a sign of low blood glucose during sleep. If you take insulin or a sulfonylurea with Ozempic and wake from nightmares sweating, treat that as a possible overnight low and tell your prescriber.

Can Ozempic make me tired during the day instead?

Daytime tiredness is better documented than night-time wakefulness. The Ozempic label lists fatigue among other adverse reactions with a frequency above 0.4 percent. The higher-dose Wegovy label reports fatigue in 11 percent of adults on 2.4 mg against 5 percent on placebo. Feeling worn out in the day is not the same problem as being unable to fall asleep.

Should I take a sleep aid or supplement while on Ozempic?

Ask the prescriber who manages your Ozempic before adding anything. The label notes that semaglutide delays gastric emptying and advises caution with oral medicines taken at the same time. It also warns that combining Ozempic with insulin or an insulin secretagogue raises hypoglycemia risk, which matters if a sleep aid makes you sleep through an overnight low.

Will losing weight on Ozempic improve my sleep?

It may, though the direct evidence involves a different drug. In SURMOUNT-OSA, tirzepatide improved the apnea-hypopnea index and patient-reported sleep measures over 52 weeks in adults with obesity and sleep apnea. A 2026 review in Nature and Science of Sleep concluded that sleep apnea outcome data for semaglutide itself remain limited.

How long do sleep problems on Ozempic usually last?

There is no labeled answer, because insomnia is not a labeled reaction. What the label does say is that most nausea, vomiting, and diarrhea reports came during dose escalation. If a symptom like night-time nausea is keeping you awake, it is reasonable to describe that pattern to your prescriber before the next dose increase.

Can Ozempic Cause Insomnia Or Trouble Sleeping?

The short answer: Insomnia is not a listed side effect of Ozempic. The FDA prescribing information for semaglutide does not name insomnia, sleep disorder, or any other sleep term, in either the clinical trial tables or the postmarketing section. When people do sleep badly on Ozempic, the cause is usually indirect: night-time nausea, reflux, or low blood sugar from a companion diabetes drug. Report new sleep trouble to your prescriber, because those causes are treatable.

Does the FDA label for Ozempic list insomnia?

No. The FDA prescribing information for Ozempic runs through every adverse reaction seen in the semaglutide trials. The word insomnia does not appear in it. Neither does sleep disorder, somnolence, or sleep disturbance.

The reactions reported in at least 5% of Ozempic-treated patients are all digestive. Nausea occurred in 15.8% of patients on 0.5 mg and 20.3% on 1 mg, against 6.1% on placebo. Vomiting, diarrhea, abdominal pain, and constipation follow. The label then names a short list of other reactions with a frequency above 0.4%: fatigue, dysgeusia (taste changes), and dizziness.

The postmarketing section lists problems reported after approval, without a known rate. It covers pancreatitis, ileus, anaphylaxis, gallbladder disease, headache, acute kidney injury, and hair loss. Sleep is absent there too.

The higher-dose semaglutide product used in the weight-loss trials tells the same story. The Wegovy label reports nausea in 44% of adults on 2.4 mg against 16% on placebo, and fatigue in 11% against 5%. It lists no insomnia and no sleep adverse reaction.

Do adverse event reports show a sleep signal?

Partly, and the detail matters more than the headline. A 2025 disproportionality analysis in the International Journal of Clinical Pharmacy searched three national reporting systems: FAERS in the United States, CVAROD in Canada, and DAEN in Australia. Across GLP-1 drugs as a group, insomnia was the second most reported psychiatric event in FAERS, with 1,861 reports (13.2% of psychiatric reports).

The per-drug numbers are the interesting part. The significant insomnia-type signal belonged to dulaglutide (reporting odds ratio 2.93, 95% CI 2.35 to 3.66) and to tirzepatide (6.13, 95% CI 4.73 to 7.95). Semaglutide's significant signals in that analysis were depressive symptoms, nervousness, panic attack, stress, and suicidal ideation. Insomnia was not one of them.

An earlier EudraVigilance analysis reviewed 31,444 reports for semaglutide, liraglutide, and tirzepatide. Psychiatric events made up 1.18% of reports, led by depression, anxiety, and suicidal ideation. Insomnia did not feature.

These databases collect what people choose to report. They cannot give you a rate, and they cannot prove cause. Read them as a hint about where to look, not as a verdict.

What can disturb your sleep indirectly?

Three routes have real support behind them.

Night-time nausea. Up to one in five patients had nausea in the Ozempic trials. The label notes that most nausea, vomiting, and diarrhea reports came during dose escalation, which makes the weeks after a dose increase the likely trouble spot. Our guide to managing nausea on Ozempic covers the practical steps.
Night-time reflux. Gastroesophageal reflux disease was reported in 1.9% and 1.5% of Ozempic patients on 0.5 mg and 1 mg, against 0% on placebo, and in 5% against 3% on Wegovy. A 2022 systematic review in Neurogastroenterology and Motility found that nocturnal reflux symptoms have a major impact on sleep quality. It recommends a step-up approach: raise the head of the bed, lengthen the gap between dinner and bedtime, sleep on the left side, then add acid-suppressing medication.
Eating much less. This one is often asserted and thinly evidenced. A 2026 network meta-analysis of 16 randomized trials in adults with overweight or obesity found no significant differences in sleep quality scores between calorie restriction patterns and a usual diet. Hunger may keep an individual awake, but restriction by itself does not appear to wreck sleep across trials.

Our broader piece on managing Ozempic side effects covers the digestive symptoms behind the first two.

Can low blood sugar at night wake you up?

Yes, and this is the one mechanism the label itself addresses. Semaglutide alone rarely drops blood sugar too low. Paired with insulin or a sulfonylurea, the risk climbs sharply.

In the Ozempic trials, documented symptomatic hypoglycemia occurred in 17.3% of patients on 0.5 mg and 24.4% on 1 mg when the drug was given with a sulfonylurea. Severe episodes, meaning episodes that needed another person's help, occurred in 0.8% and 1.2%.

The National Institute of Diabetes and Digestive and Kidney Diseases describes what a low looks like overnight. Blood glucose can drop during sleep and stay low for hours. Signs include crying out or having nightmares, sweating enough to dampen pajamas or sheets, and waking up tired, irritable, or confused. You may also sleep through it and notice nothing.

The label says the risk can be lowered by reducing the dose of the sulfonylurea or the insulin. That is a prescriber's decision, not a change to make alone. If you take either drug alongside Ozempic and wake up sweating and shaky, say so at your next visit.

Does Ozempic help obstructive sleep apnea?

Be careful with this one, because the trial everyone quotes tested a different drug. SURMOUNT-OSA, published in the New England Journal of Medicine in 2024, studied tirzepatide, not semaglutide. Two 52-week phase 3 trials enrolled adults with moderate-to-severe obstructive sleep apnea and obesity.

In trial 1, in people not using positive airway pressure, the apnea-hypopnea index fell by 25.3 events per hour with tirzepatide and 5.3 with placebo, a treatment difference of 20.0 events per hour. In trial 2, in people already on airway pressure therapy, it fell by 29.3 against 5.5, a difference of 23.8 events per hour.

On that evidence the FDA approved tirzepatide for sleep apnea. The Zepbound label now carries an indication to treat moderate to severe obstructive sleep apnea in adults with obesity. Ozempic does not carry that indication, and no semaglutide product is approved for sleep apnea. A 2026 review in JAMA Otolaryngology, Head and Neck Surgery calls the December 2024 tirzepatide approval the first medication indicated for moderate to severe sleep apnea, and reports AHI reductions of 5.7 to 21.9 events per hour across six meta-analyses of GLP-1 drugs. A 2026 narrative review in Nature and Science of Sleep concludes that direct sleep apnea outcome data for semaglutide specifically remain limited.

The practical point: untreated sleep apnea fragments sleep badly. MedlinePlus notes that breathing pauses can happen 30 times an hour or more. If you snore loudly and wake unrefreshed, ask about a sleep study rather than blaming the injection.

Does the day or time of your injection matter?

Nothing in the label supports moving your shot to sleep better. Ozempic is given once weekly, on the same day each week, at any time of day, with or without meals. The label allows the day to be changed as long as at least 48 hours separate two doses. It offers no guidance on time of day for any symptom, sleep included. Our Ozempic dosing schedule guide covers the labeled rules.

What the label does establish is the dose-escalation pattern. If your worst nights land in the days after a dose increase, that timing is worth describing to your prescriber before the next step up.

MedlinePlus notes that most chronic insomnia is secondary, meaning it is the symptom of something else: another condition, a medicine, or caffeine and alcohol. That is why the useful move is finding the cause rather than reaching for a sleep aid. If you are weighing supplements, read the evidence first, for example on whether magnesium actually helps you sleep.

The bottom line

Ozempic is not a known cause of insomnia. The FDA label does not list it, the labeled trial tables do not report it, and the pharmacovigilance signal for insomnia points at other GLP-1 drugs rather than semaglutide. If your sleep got worse after starting, look at the mechanisms that are documented: nausea, reflux, and low blood sugar when insulin or a sulfonylurea is in the mix. And if you snore and wake exhausted, sleep apnea is worth testing for on its own terms.

Last updated: September 2026. This article is for informational purposes only and does not constitute medical advice. Do not change your Ozempic dose, your insulin, or any other diabetes medicine without talking to the prescriber who manages them.